Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mercator MedicalFRA:MM2 +3.32%62 EV-to-OCF is 4.47 as of Aug. 06, 2026, which is 12% below its 10-year median of 5.08. GuruFocus rates FRA:MM2 with a GF Score™ of 62/100 and a GF Value™ of €10.68 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Mercator Medical ranks better than 55.4% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Mercator Medical's Enterprise Value is €73.4 Mil.
Mercator Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was €16.4 Mil. Therefore, Mercator Medical's EV-to-OCF for today is 4.47.
The historical rank and industry rank for Mercator Medical's EV-to-OCF or its related term are showing as below:
FRA:MM2'
s EV-to-OCF Range Over the Past 10 Years
Min: -1519.25 Med: 5.08 Max: 125.74
Current: 4.04
During the past 13 years, the highest EV-to-OCF of Mercator Medical was 125.74. The lowest was -1519.25. And the median was 5.08.
FRA:MM2's EV-to-OCF is ranked better than 55.4% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.75
vs FRA:MM2: 4.04
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Mercator Medical's PE Ratio (TTM) for today is calculated as:
Mercator Medical's share price for today is €11.84.
Mercator Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.286.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Mercator Medical EV-to-OCF Related Terms
Mercator Medical EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Mercator Medical's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Mercator Medical's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercator Medical EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Mercator Medical's EV-to-OCF falls into.
Mercator Medical's current Enterprise Value is €73.4 Mil.
Mercator Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €16.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mercator Medical (FRA:MM2) has a EV-to-OCF of 4.47 as of Aug. 06, 2026. This is 12% below median its historical median of 5.08. According to the industry distribution chart, Mercator Medical ranks #380 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 44.6%.
Is Mercator Medical's EV-to-OCF too high?
Mercator Medical's current EV-to-OCF of 4.47 is 12% below median its 10-year median of 5.08. The Medical Devices & Instruments industry median EV-to-OCF is 7.75. Mercator Medical's value of 4.47 is 42.3% below this industry median. Based on the distribution chart, Mercator Medical ranks #380 out of 852 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Mercator Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mercator Medical ranks #380 out of 852 companies for EV-to-OCF. This puts Mercator Medical in the upper half of its industry. The industry median EV-to-OCF is 7.75. Mercator Medical's value of 4.47 is 42.3% below this benchmark. While the company's 10-year median is 5.08 vs. the industry median of 7.75, Mercator Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.75, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercator Medical's current EV-to-OCF of 4.47 is 42.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercator Medical's current EV-to-OCF is 4.47, which is 12% below median its own 10-year median of 5.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Modestly Overvalued. The stock's GF Value™ is €10.68, compared to a current price of €11.84 — trading 10.9% above its estimated fair value. The current EV-to-OCF is 4.47, which is 12% below median its 10-year median of 5.08 and 42.3% below the Medical Devices & Instruments industry median of 7.75. Mercator Medical's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current EV-to-OCF is 4.47 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mercator Medical (FRA:MM2) Overvalued in 2026?
Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued.
The current stock price of €11.84 is trading 10.9% above its estimated GF Value™ of €10.68.
GuruFocus considers Mercator Medical to be Modestly Overvalued.
Key valuation signals for FRA:MM2:
EV-to-OCF: 4.47 (12% below median its 10-year median of 5.08)
GF Value™: €10.68 vs. price of €11.84 (10.9% above fair value)
Industry Position: 42.3% below the Medical Devices & Instruments median (#380 of 852)
No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
62GF Score
Get the complete analysis for FRA:MM2
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MM2 has been successfully added to your 
